Skip to content

Herpes drug has direct anti-HIV effect, could offer cheap addition to antiretroviral therapy for developing world

Fibrosis linked to rapid loss of gut CD4 cells after HIV infection

Microbicide and PrEP potential for anal sex explored further in monkey studies

Systematic review unable to confirm or deny Swiss statement on infection risk with undetectable viral load

Two novel immune therapies in early investigation: autologous dendritic cells and CD4 zeta gene-modified T cells

HIV persists in the breastmilk of HIV-positive Kenyan mothers on antiretroviral treatment

Gene that protects against malaria may increase HIV risk in Africans

Single virus often responsible for HIV infection, suggesting high barrier to infection

Indirect effects on immune activation may partially account for lingering benefits of failed antiretroviral therapy in the brain